Jiang, Xue et al. published their research in RSC Advances in 2015 | CAS: 4546-95-6

1H-1,2,3-Triazole-4,5-dicarboxylic acid (cas: 4546-95-6) belongs to triazole derivatives. The many free lone pairs in triazoles make them useful as coordination compounds, although not typically as haptic ligands. Triazole growth retardants such as uniconazole and paclobutrazol have been known to inhibit the biosynthesis of gibberellins by blocking kaurene oxidase, an P450 enzymeFormula: C4H3N3O4

LnIII ion dependent magnetism in heterometallic Cu-Ln complexes based on an azido group and 1,2,3-triazole-4,5-dicarboxylate as co-ligands was written by Jiang, Xue;Han, Song-De;Zhao, Ran;Xu, Jian;Bu, Xian-He. And the article was included in RSC Advances in 2015.Formula: C4H3N3O4 This article mentions the following:

Four Cu-Ln coordination polymers [Cu2Ln(tda)2N3(H2O)4·2H2O] (Ln = Gd (1), Tb (2), Dy (3), Sm (4), tda = 1,2,3-triazole-4,5-dicarboxylate) were synthesized by employing H3tda and azido as co-ligands. Complexes 14 exhibit the H bonded three-dimensional (3D) network and intriguing magnetic properties. Among them, 1, 3 and 4 involve antiferromagnetic interaction between metal ions, while 2 exhibits ferromagnetic behavior, demonstrating that magnetic properties could be mediated by a variety of rare earth metal ions. In the experiment, the researchers used many compounds, for example, 1H-1,2,3-Triazole-4,5-dicarboxylic acid (cas: 4546-95-6Formula: C4H3N3O4).

1H-1,2,3-Triazole-4,5-dicarboxylic acid (cas: 4546-95-6) belongs to triazole derivatives. The many free lone pairs in triazoles make them useful as coordination compounds, although not typically as haptic ligands. Triazole growth retardants such as uniconazole and paclobutrazol have been known to inhibit the biosynthesis of gibberellins by blocking kaurene oxidase, an P450 enzymeFormula: C4H3N3O4

Referemce:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Xu, Wei-liang et al. published their research in Jingxi Huagong in 2003 | CAS: 4546-95-6

1H-1,2,3-Triazole-4,5-dicarboxylic acid (cas: 4546-95-6) belongs to triazole derivatives. Triazoles exhibit substantial isomerism, depending on the positioning of the nitrogen atoms within the ring.Triazole heterocyclic structures are found to form many weak nonbond interactions with the receptors and enzymes in biological systems.Computed Properties of C4H3N3O4

Synthesis of 1H-1,2,3-triazole under microwave irradiation was written by Xu, Wei-liang;Li, Yun-zheng;Zhang, Qing-shan;Zhu, He-sun. And the article was included in Jingxi Huagong in 2003.Computed Properties of C4H3N3O4 This article mentions the following:

Starting with benzotriazole, 1H-1,2,3-triazole was synthesized through two step reactions including oxidation by potassium permanganate and decarboxylation under microwave irradiation in overall yield of 64.7%. Compared with conventional method, in the decarboxylation reaction under microwave irradiation,the reaction time was reduced from 6 h to 6 min and the yield was enhanced from 65% to 97%. The product was corroborated by 1H NMR, 13C NMR, IR and MS. In the experiment, the researchers used many compounds, for example, 1H-1,2,3-Triazole-4,5-dicarboxylic acid (cas: 4546-95-6Computed Properties of C4H3N3O4).

1H-1,2,3-Triazole-4,5-dicarboxylic acid (cas: 4546-95-6) belongs to triazole derivatives. Triazoles exhibit substantial isomerism, depending on the positioning of the nitrogen atoms within the ring.Triazole heterocyclic structures are found to form many weak nonbond interactions with the receptors and enzymes in biological systems.Computed Properties of C4H3N3O4

Referemce:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Zhang, Chiteng et al. published their research in Chemosphere in 2016 | CAS: 1614-12-6

1H-Benzo[d][1,2,3]triazol-1-amine (cas: 1614-12-6) belongs to triazole derivatives. Triazoles consist of a five-membered ring containing three nitrogen atoms and are biologically active, especially as antifungal, antimicrobial and enzyme inhibitors. Triazole growth retardants such as uniconazole and paclobutrazol have been known to inhibit the biosynthesis of gibberellins by blocking kaurene oxidase, an P450 enzymeComputed Properties of C6H6N4

Human CYP2E1-dependent mutagenicity of mono- and dichlorobiphenyls in Chinese hamster (V79)-derived cells was written by Zhang, Chiteng;Lai, Yanmei;Jin, Guifang;Glatt, Hansruedi;Wei, Qinzhi;Liu, Yungang. And the article was included in Chemosphere in 2016.Computed Properties of C6H6N4 This article mentions the following:

Polychlorinated biphenyls (PCBs) are a group of persistent organic pollutants with confirmed carcinogenicity to humans. Metabolic activation of lower chlorinated PCBs to genotoxic metabolites may involve hydroxylation and further oxidation, and some hydroxylated metabolites may be sulfo-conjugated. However, the genotoxicity of individual PCB compounds is largely unknown. In this study, 15 mono- and dichlorobiphenyls were investigated for genotoxicity using the micronucleus and Hprt mutagenicity assays in a Chinese hamster V79-derived cell line expressing both human cytochrome P 450 (CYP) 2E1 and human sulfotransferase (SULT) 1A1 (V79-hCYP2E1-hSULT1A1). All tested compounds were inactive in both assays in V79 control cells. However, eight dichlorobiphenyls strongly induced micronuclei and other congeners were weakly pos. for this endpoint in V79-hCYP2E1-hSULT1A1 cells. The effects of each PCB in V79-hCYP2E1-hSULT1A1 cells were abolished or reduced in the presence of a CYP2E1 inhibitor (1-aminobenzotriazole), or enhanced by pretreatment of the cells with (CYP2E1-inducing) ethanol, while the genotoxicity was not significantly affected by a SULT1 inhibitor (pentachlorophenol). As representative dichlorobiphenyls, PCB 5, 10, 8 and 11 (2,3-, 2,5-, 2,4′- and 3,3′-dichlorobiphenyl, resp.) strongly induced Hprt gene mutations in V79-hCYP2E1-hSULT1A1 cells in a concentration-dependent manner. This is the first indication that human CYP2E1 is capable of converting a series of dichlorobiphenyls to strong mutagens. In the experiment, the researchers used many compounds, for example, 1H-Benzo[d][1,2,3]triazol-1-amine (cas: 1614-12-6Computed Properties of C6H6N4).

1H-Benzo[d][1,2,3]triazol-1-amine (cas: 1614-12-6) belongs to triazole derivatives. Triazoles consist of a five-membered ring containing three nitrogen atoms and are biologically active, especially as antifungal, antimicrobial and enzyme inhibitors. Triazole growth retardants such as uniconazole and paclobutrazol have been known to inhibit the biosynthesis of gibberellins by blocking kaurene oxidase, an P450 enzymeComputed Properties of C6H6N4

Referemce:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Takagi, Masashi et al. published their research in Journal of Toxicological Sciences in 2016 | CAS: 1614-12-6

1H-Benzo[d][1,2,3]triazol-1-amine (cas: 1614-12-6) belongs to triazole derivatives. However, triazoles are also useful in bioorthogonal chemistry, because the large number of nitrogen atoms causes triazoles to react similar to azides. Triazole growth retardants such as uniconazole and paclobutrazol have been known to inhibit the biosynthesis of gibberellins by blocking kaurene oxidase, an P450 enzymeCategory: triazoles

Detection of metabolic activation leading to drug-induced phospholipidosis in rat hepatocyte spheroids was written by Takagi, Masashi;Sanoh, Seigo;Santoh, Masataka;Ejiri, Yoko;Kotake, Yaichiro;Ohta, Shigeru. And the article was included in Journal of Toxicological Sciences in 2016.Category: triazoles This article mentions the following:

Drug-induced phospholipidosis (PLD) is one of the adverse reactions to treatment with cationic amphiphilic drugs. Recently, simple and reliable evaluation methods for PLD have been reported. However, the predictive power of these methods for in vivo PLD induction is insufficient in some cases. To accurately predict PLD, we focused on drug metabolism and used three-dimensional cultures of hepatocytes known as spheroids. Here we used the fluorescent phospholipid dye N-(7-nitrobenz-2-oxa-1,3-diazol-4-y1)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (NBD-PE) to detect PLD induction. After 48 h exposure to 20 uM amiodarone and amitriptyline, PLD inducers. NBD-PE fluorescence in the spheroids was significantly higher than that in the control. In contrast, 1 niM acetaminophen, as a neg. control, did not increase fluorescence. Furthermore, the combination of NBD-PE fluorescence and LysoTracker Red fluorescence and the accumulation of intrinsic phospholipids reflected PLD induction in spheroids. To evaluate metabolic activation, we assessed PLD induction by loratadine. NBD-PE fluorescence intensity was significantly increased by 50 μM loratadine treatment. However, the fluorescence was markedly decreased by co-treatment with 500 μM 1-aminobenzotriazole, a broad eytochrome P 450 inhibitor. The formation of desloratadine, a metabolite of loratadine, was observed in spheroids after treatment with loratadine alone. These results showed that metabolic activation is the key factor in PLD induction by treatment with loratadine. We demonstrated that rat primary hepatocyte spheroid culture is a useful model for evaluating drug-induced PLD induction mediated by metabolic activation of the drug using the fluorescence probe technique. In the experiment, the researchers used many compounds, for example, 1H-Benzo[d][1,2,3]triazol-1-amine (cas: 1614-12-6Category: triazoles).

1H-Benzo[d][1,2,3]triazol-1-amine (cas: 1614-12-6) belongs to triazole derivatives. However, triazoles are also useful in bioorthogonal chemistry, because the large number of nitrogen atoms causes triazoles to react similar to azides. Triazole growth retardants such as uniconazole and paclobutrazol have been known to inhibit the biosynthesis of gibberellins by blocking kaurene oxidase, an P450 enzymeCategory: triazoles

Referemce:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Choi, Young Jae et al. published their research in Food and Chemical Toxicology in 2018 | CAS: 1614-12-6

1H-Benzo[d][1,2,3]triazol-1-amine (cas: 1614-12-6) belongs to triazole derivatives. Triazoles are important five-member nitrogen heterocycles involved in a wide range of industrial applications such as agrochemicals, corrosion inhibitors, dyes, optical brighteners, as well as biologically active agents.Triazole heterocyclic structures are found to form many weak nonbond interactions with the receptors and enzymes in biological systems.Computed Properties of C6H6N4

Role of cytochrome P450 enzymes in fimasartan metabolism in vitro was written by Choi, Young Jae;Lee, Ji-Yoon;Ryu, Chang Seon;Chi, Yong Ha;Paik, Soo Heui;Kim, Sang Kyum. And the article was included in Food and Chemical Toxicology in 2018.Computed Properties of C6H6N4 This article mentions the following:

Fimasartan (FMS), an angiotensin II receptor antagonist, is metabolized to FMS S-oxide, FMS N-glucuronide, oxidative desulfurized FMS (BR-A-557), and hydroxy-Bu FMSs. The purpose of this study was to characterize enzymes involved in NADPH-dependent FMS metabolism using recombinant enzymes such as cytochrome P 450 (CYP) and flavin-containing monooxygenase (FMO), as well as selective chem. inhibitors. The results showed that CYP, but not FMO, plays a major role in FMS metabolism CYP2C9, CYP3A4, and CYP3A5 were involved in the formation of FMS S-oxide, which was further metabolized to BR-A-557 by CYP3A4/5. CYP2C9 played an exclusive role in Bu hydroxylation. The specificity constant (kcat/Km) values for S-oxidation by CYP2C9, CYP3A4, and CYP3A5 were 0.21, 0.34, and 0.19μM-1•min-1, resp. The kcat/Km values of hydroxylation at the 1-, 2-/3-, and 4-Bu group in CYP2C9 were 0.0076, 0.041, and 0.035μM-1•min-1, resp. The kcat and Km values provide information for the prediction of FMS metabolism in vivo. In addition, simultaneous determination of the FMS metabolites may be used to evaluate CYP2C9 and CYP3A4/5 activity. In the experiment, the researchers used many compounds, for example, 1H-Benzo[d][1,2,3]triazol-1-amine (cas: 1614-12-6Computed Properties of C6H6N4).

1H-Benzo[d][1,2,3]triazol-1-amine (cas: 1614-12-6) belongs to triazole derivatives. Triazoles are important five-member nitrogen heterocycles involved in a wide range of industrial applications such as agrochemicals, corrosion inhibitors, dyes, optical brighteners, as well as biologically active agents.Triazole heterocyclic structures are found to form many weak nonbond interactions with the receptors and enzymes in biological systems.Computed Properties of C6H6N4

Referemce:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Taylor, E. G.’s team published research in Canadian Journal of Research, Section B: Chemical Sciences in 20;B | CAS: 53817-16-6

Canadian Journal of Research, Section B: Chemical Sciences published new progress about 53817-16-6. 53817-16-6 belongs to triazoles, auxiliary class Triazoles, name is 1H-1,2,3-Triazole-4,5-dicarbonitrile, and the molecular formula is C17H23BO4, Product Details of C4HN5.

Taylor, E. G. published the artcileDicyanotriazole. I. The conductance of dilute aqueous solutions of dicyanotriazole at 25°, Product Details of C4HN5, the publication is Canadian Journal of Research, Section B: Chemical Sciences (1942), 161-7, database is CAplus.

Previous exptl. studies of dicyanotriazole resulted in statements that the compound is an acid comparable in strength with the strong mineral acids. In the present work, measurements of the equivalent conductivity of dicyanotriazole in dilute aqueous solution give the dissociation constant of the acid as 3.378 × 10-2 at 25°; this shows it to be an acid possessing about the same strength as dichloroacetic acid. The limiting equivalent conductivity of dicyanotriazole at 25° is 384.9. The earlier work gave 397.44.

Canadian Journal of Research, Section B: Chemical Sciences published new progress about 53817-16-6. 53817-16-6 belongs to triazoles, auxiliary class Triazoles, name is 1H-1,2,3-Triazole-4,5-dicarbonitrile, and the molecular formula is C17H23BO4, Product Details of C4HN5.

Referemce:
https://en.wikipedia.org/wiki/1,2,3-Triazole,
Triazoles – an overview | ScienceDirect Topics

Salamone, John D.’s team published research in IDrugs in 13 | CAS: 377727-87-2

IDrugs published new progress about 377727-87-2. 377727-87-2 belongs to triazoles, auxiliary class GPCR/G Protein,Adenosine Receptor, name is 2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, and the molecular formula is C25H29N9O3, Formula: C25H29N9O3.

Salamone, John D. published the artcilePreladenant, a novel adenosine A2A receptor antagonist for the potential treatment of parkinsonism and other disorders, Formula: C25H29N9O3, the publication is IDrugs (2010), 13(10), 723-731, database is CAplus.

A review. Adenosine A2A receptor antagonists exert antiparkinsonian effects in animal models and several drugs in this class are currently being assessed in clin. trials. Preladenant (SCH-420814) is an adenosine A2A receptor antagonist with a high affinity and very high selectivity for adenosine A2A receptors, which is being developed by Merck & Co Inc (following its acquisition of Schering-Plough Corp) for the potential treatment of Parkinson’s disease. Preclin. studies in rodent and primate models of parkinsonism demonstrated that preladenant can reverse the motor impairments induced by dopamine depletion or antagonism. Phase I and II clin. trials indicated that preladenant was well tolerated. Moreover, preladenant met its major endpoints by reducing OFF time and increasing ON time in L-DOPA-treated patients with Parkinson’s disease, without worsening dyskinesias. Therefore, preladenant may have considerable utility for the treatment of Parkinson’s disease, as well as the parkinsonian side effects of dopamine D2 receptor antagonists. As research has suggested that adenosine A2A receptor antagonists are active in animal models of effort-based decision making, it is possible that preladenant could also be useful for treating energy-related symptoms, such as fatigue, psychomotor retardation and anergia in patients with parkinsonism or depression. At the time of publication, phase III clin. trials were recruiting patients with Parkinson’s disease.

IDrugs published new progress about 377727-87-2. 377727-87-2 belongs to triazoles, auxiliary class GPCR/G Protein,Adenosine Receptor, name is 2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, and the molecular formula is C25H29N9O3, Formula: C25H29N9O3.

Referemce:
https://en.wikipedia.org/wiki/1,2,3-Triazole,
Triazoles – an overview | ScienceDirect Topics

Salamone, John D’s team published research in IDrugs : the investigational drugs journal in 13 | CAS: 377727-87-2

IDrugs : the investigational drugs journal published new progress about 377727-87-2. 377727-87-2 belongs to triazoles, auxiliary class GPCR/G Protein,Adenosine Receptor, name is 2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, and the molecular formula is C25H29N9O3, Related Products of triazoles.

Salamone, John D published the artcilePreladenant, a novel adenosine A(2A) receptor antagonist for the potential treatment of parkinsonism and other disorders., Related Products of triazoles, the publication is IDrugs : the investigational drugs journal (2010), 13(10), 723-31, database is MEDLINE.

Adenosine A(2A) receptor antagonists exert antiparkinsonian effects in animal models and several drugs in this class are currently being assessed in clinical trials. Preladenant (SCH-420814) is an adenosine A(2A) receptor antagonist with a high affinity and very high selectivity for adenosine A(2A) receptors, which is being developed by Merck & Co Inc (following its acquisition of Schering-Plough Corp) for the potential treatment of Parkinson’s disease. Preclinical studies in rodent and primate models of parkinsonism demonstrated that preladenant can reverse the motor impairments induced by dopamine depletion or antagonism. Phase I and II clinical trials indicated that preladenant was well tolerated. Moreover, preladenant met its major endpoints by reducing OFF time and increasing ON time in l-DOPA-treated patients with Parkinson’s disease, without worsening dyskinesias. Therefore, preladenant may have considerable utility for the treatment of Parkinson’s disease, as well as the parkinsonian side effects of dopamine D2 receptor antagonists. As research has suggested that adenosine A(2A) receptor antagonists are active in animal models of effort-based decision making, it is possible that preladenant could also be useful for treating energy-related symptoms, such as fatigue, psychomotor retardation and anergia in patients with parkinsonism or depression. At the time of publication, phase III clinical trials were recruiting patients with Parkinson’s disease.

IDrugs : the investigational drugs journal published new progress about 377727-87-2. 377727-87-2 belongs to triazoles, auxiliary class GPCR/G Protein,Adenosine Receptor, name is 2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, and the molecular formula is C25H29N9O3, Related Products of triazoles.

Referemce:
https://en.wikipedia.org/wiki/1,2,3-Triazole,
Triazoles – an overview | ScienceDirect Topics

Ritchie, James P.’s team published research in Journal of Organic Chemistry in 54 | CAS: 63598-71-0

Journal of Organic Chemistry published new progress about 63598-71-0. 63598-71-0 belongs to triazoles, auxiliary class Triazole, name is 4H-1,2,4-Triazole, and the molecular formula is C2H3N3, Recommanded Product: 4H-1,2,4-Triazole.

Ritchie, James P. published the artcileStructures and energies of the tautomers and conjugate bases of some 1,2,4-triazolones, Recommanded Product: 4H-1,2,4-Triazole, the publication is Journal of Organic Chemistry (1989), 54(15), 3553-60, database is CAplus.

MO calculations at the AM1, 3-21G//3-21G, and 6-31G*//3-21G levels were performed for several possible tautomers of 1,2,4-triazol-5-one and 3-nitro-1,2,4-triazol-5-one. Calculations were also performed at the AM1, 3-21G//3-21G, and 6-31+G//3-21G levels for some conjugate bases of these compounds The results show the 1H,4H tautomer to be most stable. 5-Hydroxy-1H-1,2,4-triazole and 3-nitro-5-hydroxy-1H-1,2,4-triazole are found to lie 9.4 and 7.5 kcal/mol, resp., higher in energy than the corresponding 1H,4H isomer. The calculations may overestimate this relative energy by perhaps 1-3 kcal/mol. The calculations also predict deprotonation is most likely at N-4 of the lowest energy triazolone, but nearly equally likely at N-1 and N-4 for the corresponding nitrotriazolone (although the N-4 position is slightly favored). The substitution effects of the nitro group were examined by comparing calculated geometries, relative energies, and electrostatic potentials of the triazolones and nitrotriazolones. Electronegativity effects predominate for the neutral compounds In the conjugate bases, a significant contribution from resonance participation of the nitro group was found. Problems in using the electrostatic potential to predict the site of electrophilic substitution in the triazolone are discussed.

Journal of Organic Chemistry published new progress about 63598-71-0. 63598-71-0 belongs to triazoles, auxiliary class Triazole, name is 4H-1,2,4-Triazole, and the molecular formula is C2H3N3, Recommanded Product: 4H-1,2,4-Triazole.

Referemce:
https://en.wikipedia.org/wiki/1,2,3-Triazole,
Triazoles – an overview | ScienceDirect Topics

Pinna, Annalisa’s team published research in Expert Opinion on Investigational Drugs in 18 | CAS: 377727-87-2

Expert Opinion on Investigational Drugs published new progress about 377727-87-2. 377727-87-2 belongs to triazoles, auxiliary class GPCR/G Protein,Adenosine Receptor, name is 2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, and the molecular formula is C25H29N9O3, Application of 2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine.

Pinna, Annalisa published the artcileNovel investigational adenosine A2A receptor antagonists for Parkinson’s disease, Application of 2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, the publication is Expert Opinion on Investigational Drugs (2009), 18(11), 1619-1631, database is CAplus and MEDLINE.

A review. The development of non-dopaminergic therapies for Parkinson’s disease (PD) has attracted much interest in recent years. Among new classes of drugs, adenosine A2A antagonists have emerged as the best candidates. BIIB014, preladenant and ST-1535 are new adenosine A2A antagonists currently in Phase I and II clin. trials for evaluation of their efficacy in patients with PD. All these compounds have been proven safe and well tolerated. Moreover, results from Phase II trials also demonstrate that BIIB014 and preladenant are effective in reducing the waking time spent in OFF state in patients at the late stage of PD treated with L-DOPA. BIIB014 is also efficacious as monotherapy in patients at the early stage of PD. Finally, ST-1535, at this time, displays a very promising potential in exptl. models of PD and a safe profile in clin. studies. This review summarizes pharmacol. data available on these three A2A antagonists, their effects in animal models of PD and their profiles in clin. trials.

Expert Opinion on Investigational Drugs published new progress about 377727-87-2. 377727-87-2 belongs to triazoles, auxiliary class GPCR/G Protein,Adenosine Receptor, name is 2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, and the molecular formula is C25H29N9O3, Application of 2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine.

Referemce:
https://en.wikipedia.org/wiki/1,2,3-Triazole,
Triazoles – an overview | ScienceDirect Topics